Company intelligence / Profile preview

ArrayPatch

Ownership: Private
Development stage: Preclinical

Overview

ArrayPatch is developing a proprietary microneedle-based drug delivery technology called DerMap. Their first product, ITZ-DerMap, is being developed for the treatment of onychomycosis (nail fungal infection). The company has won several awards including Innovation of the Year at the Pharma Industry Awards 2022 and the 2023 IDEATE Ireland competition.

Therapeutic areas: OncologyEndocrinologyDermatologyNeurologyInfectious Diseases
Modalities: Microneedle-based drug delivery technology
Industry: Biotech

Drug pipeline

3 assets

ITZ-DerMap

Preclinical

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on ArrayPatch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArrayPatch.

Explore the full profile